103 related articles for article (PubMed ID: 17474072)
1. Inhibition of HIV-1 multiplication by a modified U7 snRNA inducing Tat and Rev exon skipping.
Asparuhova MB; Marti G; Liu S; Serhan F; Trono D; Schümperli D
J Gene Med; 2007 May; 9(5):323-34. PubMed ID: 17474072
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a triple combination gene therapy vector inhibiting HIV-1 multiplication.
Asparuhova MB; Barde I; Trono D; Schranz K; Schümperli D
J Gene Med; 2008 Oct; 10(10):1059-70. PubMed ID: 18642399
[TBL] [Abstract][Full Text] [Related]
3. Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors.
Riggs NL; Little SJ; Richman DD; Guatelli JC
Virology; 1994 Jul; 202(1):264-71. PubMed ID: 8009838
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
Mautino MR; Morgan RA
Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes.
Marquis J; Kämpfer SS; Angehrn L; Schümperli D
Gene Ther; 2009 Jan; 16(1):70-7. PubMed ID: 18701908
[TBL] [Abstract][Full Text] [Related]
6. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.
Liu J; Woffendin C; Yang ZY; Nabel GJ
Gene Ther; 1994 Jan; 1(1):32-7. PubMed ID: 7584057
[TBL] [Abstract][Full Text] [Related]
7. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
[TBL] [Abstract][Full Text] [Related]
8. Multigene lentiviral vectors based on differential splicing and translational control.
Zhu Y; Feuer G; Day SL; Wrzesinski S; Planelles V
Mol Ther; 2001 Oct; 4(4):375-82. PubMed ID: 11592842
[TBL] [Abstract][Full Text] [Related]
9. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A.
Liu S; Asparuhova M; Brondani V; Ziekau I; Klimkait T; Schümperli D
Nucleic Acids Res; 2004; 32(12):3752-9. PubMed ID: 15254276
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
12. Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines.
Kjerrström A; Hinkula J; Engström G; Ovod V; Krohn K; Benthin R; Wahren B
Virology; 2001 May; 284(1):46-61. PubMed ID: 11352667
[TBL] [Abstract][Full Text] [Related]
13. Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication.
Caputo A; Rossi C; Bozzini R; Betti M; Grossi MP; Barbanti-Brodano G; Balboni PG
Gene Ther; 1997 Apr; 4(4):288-95. PubMed ID: 9176513
[TBL] [Abstract][Full Text] [Related]
14. Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA.
Sood V; Unwalla H; Gupta N; Chakraborti S; Banerjea AC
AIDS; 2007 Jan; 21(1):31-40. PubMed ID: 17148965
[TBL] [Abstract][Full Text] [Related]
15. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
Fang J; Kubota S; Yang B; Zhou N; Zhang H; Godbout R; Pomerantz RJ
Virology; 2004 Dec; 330(2):471-80. PubMed ID: 15567440
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Rev function using subgenomic and genomic constructs in T and COS cells.
Favaro JP; Arrigo SJ
Virology; 1997 Feb; 228(1):29-38. PubMed ID: 9024807
[TBL] [Abstract][Full Text] [Related]
17. Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production.
Koldej R; Cmielewski P; Stocker A; Parsons DW; Anson DS
J Gene Med; 2005 Nov; 7(11):1390-9. PubMed ID: 16025547
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
[TBL] [Abstract][Full Text] [Related]
20. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.
Li MJ; Kim J; Li S; Zaia J; Yee JK; Anderson J; Akkina R; Rossi JJ
Mol Ther; 2005 Nov; 12(5):900-9. PubMed ID: 16115802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
